SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0001493152-22-020352
Filing Date
2022-07-26
Accepted
2022-07-26 16:41:43
Documents
20

Document Format Files

Seq Description Document Type Size
1 formdfan14a.htm DFAN14A 37971
2 formdfan14a_001.jpg GRAPHIC 114600
3 formdfan14a_002.jpg GRAPHIC 503639
4 formdfan14a_003.jpg GRAPHIC 106301
5 formdfan14a_004.jpg GRAPHIC 203779
6 formdfan14a_005.jpg GRAPHIC 341248
7 formdfan14a_006.jpg GRAPHIC 374164
8 formdfan14a_007.jpg GRAPHIC 97875
9 formdfan14a_008.jpg GRAPHIC 266627
10 formdfan14a_009.jpg GRAPHIC 321015
11 formdfan14a_010.jpg GRAPHIC 244774
12 formdfan14a_011.jpg GRAPHIC 313700
13 formdfan14a_012.jpg GRAPHIC 272557
14 formdfan14a_013.jpg GRAPHIC 300162
15 formdfan14a_014.jpg GRAPHIC 94147
16 formdfan14a_015.jpg GRAPHIC 354212
17 formdfan14a_016.jpg GRAPHIC 188531
18 formdfan14a_017.jpg GRAPHIC 221454
19 formdfan14a_018.jpg GRAPHIC 81053
20 formdfan14a_019.jpg GRAPHIC 263536
  Complete submission text file 0001493152-22-020352.txt   6461811
Mailing Address CAMAC CAPITAL, LLC 350 PARK AVENUE, 13TH FLOOR NEW YORK NY 10022
Business Address CAMAC CAPITAL, LLC 350 PARK AVENUE, 13TH FLOOR NEW YORK NY 10022 914-629-8496
Camac Fund, LP (Filed by) CIK: 0001516478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A

Mailing Address 2110 NARCISSUS CT VENICE CA 90291
Business Address 2110 NARCISSUS CT VENICE CA 90291 8184226172
Pasithea Therapeutics Corp. (Subject) CIK: 0001841330 (see all company filings)

IRS No.: 851591963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A | Act: 34 | File No.: 001-40804 | Film No.: 221107589
SIC: 2834 Pharmaceutical Preparations